Susceptible IL-13 transgenic C57BL/6 mice develop impaired IL-12 and IFN-γ production during acute leishmaniasis, while IL-13−/− BALB/c mice remain comparatively resistant [4,22]. This evidence concerns the gene IL13 and leishmaniasis.